Short answer · Medically reviewed summary · Last updated: 2026-04-07
The ICD-10 code for IgA nephropathy is N02.8 (recurrent and persistent hematuria with focal glomerulonephritis), though it is frequently categorized under N04.8 (nephrotic syndrome) or N05.8 (unspecified nephritic syndrome) depending on clinical presentation. In the older ICD-9-CM classification system, IgA nephropathy was primarily coded as 583.2 (nephritis and nephropathy, not specified as acute or chronic, with lesion of proliferative glomerulonephritis). What exactly is IgA nephropathy? IgA nephropathy, also known as Berger’s disease, is a chronic autoimmune kidney disorder that occurs when immunoglobulin A (IgA)—an antibody that typically helps the body fight infections—deposits in the glomeruli.
The ICD-10 code for IgA nephropathy is N02.8 (recurrent and persistent hematuria with focal glomerulonephritis), though it is frequently categorized under N04.8 (nephrotic syndrome) or N05.8 (unspecified nephritic syndrome) depending on clinical presentation. In the older ICD-9-CM classification system, IgA nephropathy was primarily coded as 583.2 (nephritis and nephropathy, not specified as acute or chronic, with lesion of proliferative glomerulonephritis).
IgA nephropathy, also known as Berger’s disease, is a chronic autoimmune kidney disorder that occurs when immunoglobulin A (IgA)—an antibody that typically helps the body fight infections—deposits in the glomeruli. These are the tiny filtering units within the kidneys. Over time, the buildup of IgA nephropathy causes inflammation, which can impair the kidneys' ability to filter waste products from the blood. Currently, 347 people with IgA nephropathy are active in the DiseaseMaps community, sharing their personal experiences with symptom management and treatment journeys.
While the ICD-10 code N02.8 is the most specific representation for the hematuric presentation of IgA nephropathy, medical coding is highly nuanced. Because IgA nephropathy manifests differently in every patient—ranging from asymptomatic microscopic hematuria to rapid-onset nephrotic syndrome—physicians may use a range of codes to reflect the patient's specific clinical status. Accurate coding is essential not only for insurance reimbursement but also for epidemiological tracking, which helps researchers better understand the global prevalence of IgA nephropathy.
The progression of IgA nephropathy is often slow, sometimes spanning decades. Because many patients are asymptomatic in the early stages, the disease is frequently detected during routine physicals. Common clinical markers that lead to an IgA nephropathy diagnosis include:
While IgA nephropathy is not considered a classic Mendelian hereditary disease, research indicates a strong genetic predisposition. Studies have identified several susceptibility loci, particularly within the major histocompatibility complex (MHC) region. However, environmental triggers and mucosal immune responses play a significant role in the development of IgA nephropathy, meaning that having a genetic marker does not guarantee the development of the condition.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.